corbadrine has been researched along with medetomidine in 1 studies
| Studies (corbadrine) | Trials (corbadrine) | Recent Studies (post-2010) (corbadrine) | Studies (medetomidine) | Trials (medetomidine) | Recent Studies (post-2010) (medetomidine) |
|---|---|---|---|---|---|
| 20 | 0 | 12 | 1,335 | 296 | 444 |
| Protein | Taxonomy | corbadrine (IC50) | medetomidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalton, JT; Feller, DR; George, C; Hsu, FL; Lei, L; Miller, DD; Patil, PN; Shams, G; Yao, XT; Zhang, X | 1 |
1 other study(ies) available for corbadrine and medetomidine
| Article | Year |
|---|---|
Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.
Topics: Adrenergic alpha-Agonists; Animals; Aorta; Cell Membrane; Cerebral Cortex; Crystallography, X-Ray; Drug Design; Female; Humans; Imidazoles; Male; Medetomidine; Models, Molecular; Molecular Conformation; Molecular Structure; Muscle Contraction; Naphthalenes; Platelet Aggregation Inhibitors; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1996 |